Zhijian James Chen

Scientific Advisor at Drug Farm

Zhijian James Chen is the George L. MacGregor Distinguished Chair in Biomedical Science, director of the Inflammation Research Center, and a professor of molecular biology at the University of Texas Southwestern Medical Center. He is also an investigator at the Howard Hughes Medical Institute. Dr. Chen received his PhD in biochemistry from SUNY Buffalo. Dr. Chen’s research focuses on the biochemical pathways of immunity. His research into complex cellular biochemistry has led to the discovery of pathways and proteins that trigger immune and stress responses. He has identified proteins, such as the mitochondrial protein MAVS, that are crucial to the body’s defense against RNA viruses such as influenza and Ebola. Dr. Chen was awarded with the 2019 Breakthrough Prize in Life Sciences for elucidating how DNA triggers immune and autoimmune responses from the interior of a cell through the discovery of the DNA-sensing enzyme cGAS.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Drug Farm

2 followers

As a China and US based biotech, Drug Farm is developing first-in-class drugs in the fields of hepatitis B, cancer and autoimmune diseases using its platform mouse genetics and AI technologies.


Industries

Headquarters

Shanghai, China

Employees

51-200

Links